Al-Modawat Specialized Medical Company (TADAWUL: 9594)

Al-Modawat Specialized Medical Company Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	10.82	18.59	10.31	-2.21
Depreciation & Amortization	4.23	3.66	2.1	1.92
Other Amortization	0.01	0.01	0.01	0.01
Other Operating Activities	3.18	2.57	1.37	-0.59
Change in Accounts Receivable	-8.88	-16.19	-9.43	3.06
Change in Inventory	-0.9	-1.67	-0.68	1.61
Change in Accounts Payable	1.82	0.23	-1.53	-0.01
Change in Other Net Operating Assets	-8.94	5.05	1.99	-1.51
Operating Cash Flow	2.31	13.6	5.09	2.27
Operating Cash Flow Growth	-85.30%	167.08%	124.19%	-
Capital Expenditures	-6.4	-3.92	-2.77	-4.53
Sale (Purchase) of Intangibles	-0	-	-0.01	-0
Investing Cash Flow	-6.37	-3.92	-2.78	-4.53
Long-Term Debt Issued	-	2.82	-	7.41
Long-Term Debt Repaid	-	-3.46	-7.02	-0.52
Net Debt Issued (Repaid)	-5.55	-0.65	-7.02	6.9
Common Dividends Paid	-23.09	-9.35	-	-
Other Financing Activities	-0.8	-0.8	-0.67	-
Financing Cash Flow	23.29	-10.79	-7.69	6.9
Net Cash Flow	19.23	-1.12	-5.38	4.64
Free Cash Flow	-4.09	9.68	2.32	-2.26
Free Cash Flow Growth	-	317.48%	-	-
Free Cash Flow Margin	-5.50%	13.03%	3.96%	-5.53%
Free Cash Flow Per Share	-0.20	0.51	0.12	-
Cash Interest Paid	0.8	0.8	0.67	-
Levered Free Cash Flow	-9.56	3.91	-1.7	-
Unlevered Free Cash Flow	-8.86	4.62	-1.27	-
Change in Net Working Capital	15.53	8.8	8.18	-

Source: S&P Capital IQ. Standard template. Financial Sources.